Innovation

Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms

From left, Dandan Liu, PhD, Alan Storrow, MD, and Sunil Kripalani, MD, MSc, are testing the real-world implementation of a risk stratification tool to avoid unnecessary hospital admissions of patients diagnosed with acute heart failure in the emergency department.

VUMC team puts tool to reduce heart failure admissions to test

Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.

‘DNA’ podcast Season 2 explores COVID, science and trust in communities

First Listen: Season 2 ‘Vanderbilt Health DNA’ podcast trailer

New episodes of the #ListenDNA podcast series drop every week starting Aug. 23. 

VUMC’s DNA podcast garners award

Vanderbilt University Medical Center’s original podcast series, Vanderbilt Health DNA: Discoveries in Action, was named Healthcare Podcast of the Year at the 2021 Healthcare and IT Marketing Community (HITMC) Awards.  

1 3 4 5 6 7